Correlation Between Eliem Therapeutics and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Larimar Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Larimar Therapeutics.
Diversification Opportunities for Eliem Therapeutics and Larimar Therapeutics
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Eliem and Larimar is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Larimar Therapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 1.21 times less return on investment than Larimar Therapeutics. In addition to that, Eliem Therapeutics is 1.29 times more volatile than Larimar Therapeutics. It trades about 0.04 of its total potential returns per unit of risk. Larimar Therapeutics is currently generating about 0.07 per unit of volatility. If you would invest 364.00 in Larimar Therapeutics on September 2, 2024 and sell it today you would earn a total of 269.00 from holding Larimar Therapeutics or generate 73.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.19% |
| Values | Daily Returns |
Eliem Therapeutics vs. Larimar Therapeutics
Performance |
| Timeline |
| Eliem Therapeutics |
| Larimar Therapeutics |
Eliem Therapeutics and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Larimar Therapeutics
The main advantage of trading using opposite Eliem Therapeutics and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |